| abstract |
QUINOLINON FORMULATIONS. The present invention relates to a pharmaceutical formulation comprising: a compound of formula (I), a compound tautomer, a compound salt, a tautomer salt, or a mixture thereof and at least one ingredient selected from the group which consists of (i) cellulose; (ii) silicon dioxide; (iii) magnesium stearate; and (iv) an ingredient selected from crospovidone, starch or lactose. |